Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 28.11.2016 | EN | Official Journal of the European Union | C 441/19 |

---

Action brought on 12 September 2016 — Gall Pharma v EUIPO — Pfizer (Styriagra)

(Case T-662/16)

(2016/C 441/24)

Language in which the application was lodged: German

Parties

Applicant: Gall Pharma GmbH (Judenburg, Austria) (represented by: D. Reichelt and L. Figura, lawyers)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Pfizer Inc. (New York, New York, United States)

Details of the proceedings before EUIPO

Applicant for registration of the trade mark at issue: Applicant

Trade mark at issue: EU word mark ‘Styriagra’ — EU trade mark application No 12 161 469

Proceedings before EUIPO: Opposition proceedings

Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 13 June 2016 in Case R 724/2015-5

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision and reject the opposition (Opposition Procedure No 002286568) to Community trade mark No 000233890; |

|  |  |
| --- | --- |
| — | order the defendant to pay the costs. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(5) of Regulation No 207/2009; |

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation No 207/2009. |

---

[Top](#document1)